Use of osteobiologics in the management of osteoporotic fractures

Journal of Orthopaedic Trauma

Volumn 25, Issue SUPPL. 1, 2011, Pages

  Nauth, Aaron ^a   Miclau, Theodore ^b   Bhandari, Mohit ^c   Schemitsch, Emil H ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

allograft; bisphosphonates; bone morphogenetic protein; calcium phosphate cement; fracture healing; osteobiologics; Osteoporosis; parathyroid hormone; plateletderived growth factor

Indexed keywords

AUGMENT; BISPHOSPHONIC ACID DERIVATIVE; BONE CEMENT; CALCIUM PHOSPHATE; GEM 21S; INFUSE; OP 1; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PLACEBO; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1; UNCLASSIFIED DRUG; ANABOLIC AGENT; BONE MORPHOGENETIC PROTEIN; CEMENT; OSTEOBIOLOGIC AGENT; PLATELET DERIVED GROWTH FACTOR;

ANKLE FRACTURE; BONE ALLOGRAFT; BONE DEVELOPMENT; BONE MARROW CELL; BONE PLATE; BONE SCREW; CLINICAL EFFECTIVENESS; CONFERENCE PAPER; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMUR FRACTURE; FEMUR HEAD PROSTHESIS; FOOT FRACTURE; FRACTURE FIXATION; FRACTURE HEALING; FRACTURE NONUNION; FRAGILITY FRACTURE; HORMONAL THERAPY; HUMAN; MITOGENESIS; NONHUMAN; OSTEOPOROSIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; RADIUS FRACTURE; TOTAL HIP PROSTHESIS; DRUG MECHANISM; REVIEW; WOUND HEALING;

BIOCOMPATIBLE MATERIALS; BONE CEMENTS; BONE DENSITY CONSERVATION AGENTS; BONE MORPHOGENETIC PROTEINS; BONE SUBSTITUTES; BONE TRANSPLANTATION; CALCIUM PHOSPHATES; DIPHOSPHONATES; FRACTURE FIXATION; FRACTURE HEALING; FRACTURES, SPONTANEOUS; HUMANS; ORTHOPEDIC PROCEDURES; OSTEOGENESIS; OSTEOPOROSIS; PARATHYROID HORMONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 79957843490     PISSN: 08905339     EISSN: 15312291     Source Type: Journal    
DOI: 10.1097/BOT.0b013e31821b8c52     Document Type: Conference Paper

References (43)

1. Giannoudis P, Tzioupis C, Almalki T, et al. Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury. 2007;38(Suppl 1):S90-S99. (Pubitemid 46440934)
2. Li X, Nishimura I. Altered bone remodeling pattern of the residual ridge in ovariectomized rats. J Prosthet Dent. 1994;72:324-330.
3. Meyer RA Jr, Tsahakis PJ, Martin DF, et al. Age and ovariectomy impair both the normalization of mechanical properties and the accretion of mineral by the fracture callus in rats. J Orthop Res. 2001;19:428-435. (Pubitemid 32472013)
4. Lill CA, Hesseln J, Schlegel U, et al. Biomechanical evaluation of healing in a non-critical defect in a large animal model of osteoporosis. J Orthop Res. 2003;21:836-842. (Pubitemid 37045561)
5. Namkung-Matthai H, Appleyard R, Jansen J, et al. Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone. 2001;28:80-86. (Pubitemid 32112065)
6. Nikolaou VS, Efstathopoulos N, Kontakis G, et al. The influence of osteoporosis in femoral fracture healing time. Injury. 2009;40:663-668.
7. Veitch SW, Stroud RM, Toms AD. Compaction bone grafting in tibial plateau fracture fixation. J Trauma. 2010;68:980-983.
8. Rajan GP, Fornaro J, Trentz O, et al. Cancellous allograft versus autologous bone grafting for repair of comminuted distal radius fractures: a prospective, randomized trial. J Trauma. 2006;60:1322-1329.
9. Chandler HP, King D, Limbird R, et al. The use of cortical allograft struts for fixation of fractures associated with well-fixed total joint prostheses. Semin Arthroplasty. 1993;4:99-107.
10. Haddad FS, Duncan CP, Berry DJ, et al. Periprosthetic femoral fractures around well-fixed implants: use of cortical onlay allografts with or without a plate. J Bone Joint Surg Am. 2002;84:945-950.
11. Sanchez-Sotelo J, O'Driscoll S, Morrey BF. Periprosthetic humeral fractures after total elbow arthroplasty: treatment with implant revision and strut allograft augmentation. J Bone Joint Surg Am. 2002;84:1642-1650. (Pubitemid 35014716)
12. Van Houwelingen AP, McKee MD. Treatment of osteopenic humeral shaft nonunion with compression plating, humeral cortical allograft struts, and bone grafting. J Orthop Trauma. 2005;19:36-42. (Pubitemid 40309436)
13. Wang JW, Weng LH. Treatment of distal femoral nonunion with internal fixation, cortical allograft struts, and autogenous bone-grafting. J Bone Joint Surg Am. 2003;85:436-440.
14. Wang JW, Wang CJ. Supracondylar fractures of the femur above total knee arthroplasties with cortical allograft struts. J Arthroplasty. 2002;17:365-372.
15. Kumar A, Chambers I, Maistrelli G, et al. Management of periprosthetic fracture above total knee arthroplasty using intramedullary fibular allograft and plate fixation. J Arthroplasty. 2008;23:554-558.
16. Goodman SB, Bauer TW, Carter D, et al. Norian SRS cement augmentation in hip fracture treatment. Laboratory and initial clinical results. Clin Orthop Relat Res. 1998;348:42-50. (Pubitemid 28160803)
17. Mattsson P, Larsson S. Calcium phosphate cement for augmentation did not improve results after internal fixation of displaced femoral neck fractures: a randomized study of 118 patients. Acta Orthop. 2006;77:251-256.
18. Mattsson P, Alberts A, Dahlberg G, et al. Resorbable cement for the augmentation of internally-fixed unstable trochanteric fractures. A prospective, randomised multicentre study. J Bone Joint Surg Br. 2005;87:1203-1209. (Pubitemid 41387558)
19. Russell TA, Leighton RK. Comparison of autogenous bone graft and endothermic calcium phosphate cement for defect augmentation in tibial plateau fractures. A multicenter, prospective, randomized study. J Bone Joint Surg Am. 2008;90:2057-2061.
20. Bajammal SS, Zlowodzki M, Lelwica A, et al. The use of calcium phosphate bone cement in fracture treatment. A meta-analysis of randomized trials. J Bone Joint Surg Am. 2008;90:1186-1196. (Pubitemid 351778124)
21. Giannoudis PV, Einhorn TA. Bone morphogenetic proteins in musculoskeletal medicine. Injury. 2009;40(suppl 3):S1-S3.
22. Pountos I, Georgouli T, Henshaw K, et al. The effect of bone morphogenetic protein-2, bone morphogenetic protein-7, parathyroid hormone, and platelet-derived growth factor on the proliferation and osteogenic differentiation of mesenchymal stem cells derived from osteoporotic bone. J Orthop Trauma. 2010;24:552-556.
23. Li M, Liu X, Ge B. Calcium phosphate cement with BMP-2-loaded gelatin microspheres enhances bone healing in osteoporosis: a pilot study. Clin Orthop Relat Res. 2010;468:1978-1985.
24. Tang Y, Tang W, Lin Y, et al. Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats. Cell Biol Int. 2008;32:1150-1157.
25. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83(suppl 1):S151-S158.
26. Ronga M, Baldo F, Zappala G, et al. Recombinant human bone morphogenetic protein-7 for treatment of long bone non-union: an observational, retrospective, non-randomized study of 105 patients. Injury. 2006;37(suppl 3):S51-S56. (Pubitemid 46107007)
27. Jones AL, Bucholz RW, Bosse MJ, et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am. 2006;88:1431-1441.
28. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84:2123-2134. (Pubitemid 35417689)
29. Hollinger JO, Hart CE, Hirsch SN, et al. Recombinant human plateletderived growth factor: biology and clinical applications. J Bone Joint Surg Am. 2008;90(suppl 1):48-54. (Pubitemid 351329121)
30. Hollinger JO, Onikepe AO, MacKrell J, et al. Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res. 2008;26:83-90.
31. Mitlak BH, Finkelman RD, Hill EL, et al. The effect of systemically administered PDGF-BB on the rodent skeleton. J Bone Miner Res. 1996;11:238-247. (Pubitemid 26057432)
32. Daniels T, DiGiovanni C, Lau JT, et al. Prospective clinical pilot trial in a single cohort group of rhPDGF in foot arthrodeses. Foot Ankle Int. 2010;31:473-479.
33. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434-1441. (Pubitemid 32402100)
34. Nozaka K, Miyakoshi N, Kasukawa Y, et al. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone. 2008;42:90-97. (Pubitemid 350297177)
35. Komrakova M, Stuermer EK, Werner C, et al. Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone. 2010;47:480-492.
36. Yu CT, Wu JK, Chang CC, et al. Early callus formation in human hip fracture treated with internal fixation and teriparatide. J Rheumatol. 2008;35:2082-2083.
37. Rubery PT, Bukata SV. Teriparatide may accelerate healing in delayed unions of type III odontoid fractures: a report of 3 cases. J Spinal Disord Tech. 2010;23:151-155.
38. Aspenberg P, Genant HK, Johansson T, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res. 2010;25:404-414.
39. Morris CD, Einhorn TA. Bisphosphonates in orthopaedic surgery. J Bone Joint Surg Am. 2005;87:1609-1618. (Pubitemid 40917766)
40. Goodship AE, Walker PC, McNally D, et al. Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol. 1994;5(suppl 7):S53-S55.
41. Adolphson P, Abbaszadegan H, Boden H, et al. Clodronate increases mineralization of callus after Colles' fracture: a randomized, double-blind, placebo-controlled, prospective trial in 32 patients. Acta Orthop Scand. 2000;71:195-200. (Pubitemid 30611747)
42. Colon-Emeric C, Nordsletten L, Olson S, et al. Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int. 2010 Dec. 9 [Epub ahead of print].
43. Moroni A, Faldini C, Hoang-Kim A, et al. Alendronate improves screw fixation in osteoporotic bone. J Bone Joint Surg Am. 2007;89:96-101. (Pubitemid 46059148)